| [1] |
Greco L, Chegai F, Pensabene MC, et al. Early detection of hepatic encephalopathy after transjugular intrahepatic portsystemic shunt using multiparametric magnetic resonance with spectroscopy[J]. European Journal of Radiology Open, 2019, 6: 350-357.
|
| [2] |
Karanfilian BV, Park T, Senatore F, et al. Minimal hepatic encephalopathy[J]. Clin Liver Dis, 2020, 24(2): 209-218.
|
| [3] |
曹家伟, 丁鹏绪, 段峰, 等. 中国门静脉高压经颈静脉肝内门体分流术临床实践指南(2019年版)[J]. 临床肝胆病杂志, 2019, 35(12): 2694-2699.
|
| [4] |
Luo M, Ma P, Li L, et al. Advances in psychometric tests for screening minimal hepatic encephalopathy: from paper-and-pencil to computer-aided assessment[J]. Turk J Gastroenterol, 2019, 30(5): 398-407.
|
| [5] |
Pawar VB, Surude RG, Sonthalia N, et al. Minimal hepatic encephalopathy in Indians: psychometric hepatic encephalopathy score and inhibitory control test for diagnosis and rifaximin or lactulose for its reversal[J]. J Clin Transl Hepatol, 2019, 7(4): 304-312.
|
| [6] |
Lauridsen MM, Thiele M, Kimer N, et al. The continuous reaction times method for diagnosing, grading, and monitoring minimal/covert hepatic encephalopathy[J]. Metabolic Brain Disease, 2013, 28(2): 231-234.
|
| [7] |
Allampati S, Duarte-Rojo A, Thacker LR, et al. Diagnosis of minimal hepatic encephalopathy using stroop encephalApp: a multicenter US-based, norm-based study[J]. The American Journal of Gastroenterology, 2016, 111(1): 78-86.
|
| [8] |
Springate BA, Carvalho JO. Factor structure of the repeatable battery for the assessment of neuropsychological status in huntington's disease[J]. Arch Clin Neuropsychol, 2022, 37(2): 473-478.
|
| [9] |
Nabi E, Thacker LR, Wade JB, et al. Diagnosis of covert hepatic encephalopathy without specialized tests[J]. Clin Gastroenterol Hepatol, 2014, 12(8): 1384-1389.e2.
|
| [10] |
Giménez-Garzó C, Garcés JJ, Urios A, et al. The PHES battery does not detect all cirrhotic patients with early neurological deficits, which are different in different patients[J]. PloS One, 2017, 12(2): e0171211.
|
| [11] |
Metwally MA, Biomy HA, Omar MZ, et al. Critical flickering frequency test: a diagnostic tool for minimal hepatic encephalopathy[J]. Eur J Gastroenterol Hepatol, 2019, 31(8): 1030-1034.
|
| [12] |
Jackson CD, Gram M, Halliday E, et al. New spectral thresholds improve the utility of the electroencephalogram for the diagnosis of hepatic encephalopathy[J]. Clin Neurophysid, 2016, 127(8): 2933-2941.
|
| [13] |
Alonso J, Córdoba J, Rovira A. Brain magnetic resonance in hepatic encephalopathy[J]. Semin Ultrasound CT MR, 2014, 35(2): 136-152.
|
| [14] |
李朝先, 倪润, 琚坚. 经颈静脉肝内门体分流术后并发肝性脑病的研究进展[J]. 中国社区医师, 2023, 39(4): 13-15.
|
| [15] |
罗松, 张龙江, 卢光明. 肝性脑病神经影像学研究新进展[J]. 放射学实践, 2014, 29(1): 36-39.
|
| [16] |
Jain L, Sharma BC, Srivastava S, et al. Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy[J]. Journal of Gastroenterology and Hepatology, 2013, 28(7): 1187-1193.
|
| [17] |
Qi R, Zhang LJ, Zhong J, et al. Grey and white matter abnormalities in minimal hepatic encephalopathy: a study combining voxel-based morphometry and tract-based spatial statistics[J]. Eur Radiol, 2013, 23(12): 3370-3378.
|
| [18] |
刘梅红, 刘辉, 张岚, 等. 轻微型肝性脑病磁共振扩散加权成像和扩散张量成像的定量研究[J]. 中国实用神经疾病杂志, 2020, 23(4): 340-344.
|
| [19] |
Sato T, Endo K, Kakisaka K, et al. Decreased mean kurtosis in the putamen is a diagnostic feature of minimal hepatic encephalopathy in patients with cirrhosis[J]. Internal Medicine (Tokyo, Japan), 2019, 58(9): 1217-1224.
|
| [20] |
Li JL, Jiang H, Zhang XD, et al. Microstructural brain abnormalities correlate with neurocognitive dysfunction in minimal hepatic encephalopathy: a diffusion kurtosis imaging study[J]. Neuroradiology, 2019, 61(6): 685-694.
|
| [21] |
Felipo V, Urios A, Giménez-Garzó C, et al. Non invasive blood flow measurement in cerebellum detects minimal hepatic encephalopathy earlier than psychometric tests[J]. World Journal of Gastroenterology, 2014, 20(33): 11815-11825.
|
| [22] |
Zheng G, Zhang LJ, Zhong J, et al. Cerebral blood flow measured by arterial-spin labeling MRI: a useful biomarker for characterization of minimal hepatic encephalopathy in patients with cirrhosis[J]. European Journal of Radiology, 2013, 82(11): 1981-1988.
|
| [23] |
Zheng G, Zhang LJ, Cao Y, et al. Transjugular intrahepatic portosystemic shunt induced short- and long-term cerebral blood flow variations in cirrhotic patients: an arterial spin labeling MRI study[J]. Metabolic Brain Disease, 2013, 28(3): 463-471.
|
| [24] |
Chen QF, Chen HJ, Liu J, et al. Machine learning classification of cirrhotic patients with and without minimal hepatic encephalopathy based on regional homogeneity of intrinsic brain activity[J]. PloS One, 2016, 11(3): e0151263.
|
| [25] |
Tao R, Zhang J, You Z, et al. The thalamus in cirrhotic patients with and without hepatic encephalopathy: a volumetric MRI study[J]. European Journal of Radiology, 2013, 82(11): e715-720.
|
| [26] |
Zu Z. Towards the complex dependence of MTR(asym) on T(1w) in amide proton transfer (APT) imaging[J]. NMR in Biomedicine, 2018, 31(7): e3934.
|
| [27] |
Zöllner HJ, Butz M, Kircheis G, et al. Ammonia-weighted imaging by chemical exchange saturation transfer MRI at 3 T[J]. NMR in Biomedicine, 2018, 31(9): e3947.
|
| [28] |
Hagiwara A, Warntjes M, Hori M, et al. SyMRI of the brain: rapid quantification of relaxation rates and proton density, with synthetic MRI, automatic brain segmentation, and myelin measurement[J]. Investigative Radiology, 2017, 52(10): 647-657.
|
| [29] |
刘文潇, 党佩, 杨旭宏, 等. 集成磁共振成像在轻微型肝性脑病临床应用中的初探[J]. 磁共振成像, 2022, 13(5): 6-10+6.
|
| [30] |
Grist JT, Miller JJ, Zaccagna F, et al. Hyperpolarized 13C MRI: a novel approach for probing cerebral metabolism in health and neurological disease[J]. J Cereb Blood Flow Metab, 2020, 40(6): 1137-1147.
|
| [31] |
Guglielmetti C, Najac C, Didonna A, et al. Hyperpolarized 13C MR metabolic imaging can detect neuroinflammation in vivo in a multiple sclerosis murine model[J]. Proc Natl Acad Sci USA, 2017, 114(33): e6982-e6991.
|
| [32] |
Autry AW, Park I, Kline C, et al. Pilot study of hyperpolarized 13C metabolic imaging in pediatric patients with diffuse intrinsic pontine glioma and other CNS cancers[J]. AJNR Am J Neuroradiol, 2021, 42(1): 178-184.
|
| [33] |
Josan S, Billingsley K, Orduna J, et al. Assessing inflammatory liver injury in an acute CCl4 model using dynamic 3D metabolic imaging of hyperpolarized [1-(13)C]pyruvate[J]. NMR in Biomedicine, 2015, 28(12): 1671-1677.
|
| [34] |
Grist J T, McLean M A, Riemer F, et al. Quantifying normal human brain metabolism using hyperpolarized [1-13C]pyruvate and magnetic resonance imaging[J]. Neuroimage, 2019, 189: 171-179.
|
| [35] |
Li Y, Liu H, Yang J, et al. Combining arterial-spin labeling with functional magnetic resonance imaging measurement for characterizing patients with minimal hepatic encephalopathy[J]. Hepatol Res, 2017, 47(9): 862-871.
|
| [36] |
Vernuccio F, Cannella R, Comelli A, et al. Radiomics and artificial intelligence: new frontiers in medicine[J]. Recenti Prog Med, 2020, 111(3): 130-135.
|
| [37] |
Luo S, Zhou ZM, Guo DJ, et al. Radiomics-based classification models for HBV-related cirrhotic patients with covert hepatic encephalopathy[J]. Brain and Behavior, 2021, 11(2): e01970.
|
| [38] |
Sparacia G, Parla G, Cannella R, et al. Brain magnetic resonance imaging radiomics features associated with hepatic encephalopathy in adult cirrhotic patients[J]. Neuroradiology, 2022, 64(10): 1969-1978.
|
| [39] |
Vankadari K, Mittal B R, Kumar R, et al. Detection of hepatic encephalopathy on 18F-FDG PET/CT brain images in a patient with decompensated liver cirrhosis[J]. Clinical Nuclear Medicine, 2018, 43(12): e486-e487.
|
| [40] |
Yin X, Zhang F, Guo H, et al. A nomogram to predict the risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in Cirrhotic Patients[J]. Scientific Reports, 2020, 10(1): 9381.
|